CareDx, Inc.

CDNA

On October 28, 2021, after the market closed, transplant diagnostics company, CareDx, Inc. released Q3 2021 financial results in which the Company disclosed it is being investigated by the U.S. Department of Justice (“DOJ”) related to its kidney testing and phlebotomy services. The Company is also being investigated by the U.S. Securities and Exchange Commission (“SEC”) for similar issues as well as certain accounting and public reporting practices, and the Company received an information request from an unnamed state agency.

On this news shares of CareDx fell over 25% trading on October 29, 2021.

Lead Plaintiff deadline
class period
to
Case Documents
No documents available. Contact us if you need a case document.